In accordance with this hypothesis, it was already demonstrated that patients with nonalcoholic fatty liver disease (NAFLD) have increased serum concentration of TGs but not ApoB. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.